1. Gavrilova SI, Kalyn YaB, Kolykhalov IV, Mikhailova NM, Roshina IF, Selezneva ND, Sharikov GA, Radzivill GG. Akatinol memantine — a modulator of the glutamatergic system in the treatment of Alzheimer’s-type dementia. Sots Klin Psikhiat. 1995;5(2):78-89. (In Russ.)
2. NMDA Receptor-Dependent Synaptic Reinforcement as a Crucial Process for Memory Consolidation
3. National Institute for Health and Clinical Excellence. Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease. NICE Technology Appraisal Guidance. 2011;217.
4. Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson' disease
5. Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data